Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China · Delayed Price · Currency is CNY 8.93
+0.02 (0.22%)
Oct 30, 2025, 9:45 AM CST
SHE:002550 Revenue
Changzhou Qianhong Biopharma CO.,LTD had revenue of 353.24M CNY in the quarter ending September 30, 2025, with 0.35% growth. This brings the company's revenue in the last twelve months to 1.53B, down -1.43% year-over-year. In the year 2024, Changzhou Qianhong Biopharma CO.,LTD had annual revenue of 1.53B, down -15.88%.
Revenue (ttm)
1.53B
Revenue Growth
-1.43%
P/S Ratio
7.27
Revenue / Employee
1.57M
Employees
979
Market Cap
11.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.53B | -288.03M | -15.88% |
| Dec 31, 2023 | 1.81B | -489.28M | -21.24% |
| Jan 1, 2023 | 2.30B | 428.61M | 22.86% |
| Jan 1, 2022 | 1.87B | 207.33M | 12.43% |
| Dec 31, 2020 | 1.67B | -7.55M | -0.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| WuXi AppTec | 43.07B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Jiangsu Hengrui Medicine | 30.98B |
| Zhejiang NHU Company | 22.87B |
| Aier Eye Hospital Group | 21.94B |